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Abstract
This study aimed to examine the prognostic 
value of lipid parameters for incident hyperten-
sion in elderly living in a community. The study 
included 306 (81% from total) persons aged ≥ 60 
years who were free of hypertension and of car-
diovascular diseases at the baseline survey of the 
Bambuí Cohort Study of Aging. The cumulative 
incidence of hypertension over three years was 
37.3%. The relative risk (RR) of incident hyper-
tension decreased 0.92 for each unit of HDL-cho-
lesterol (95%CI: 0.86-0.99) independent of several 
potential confounding factors. Individuals with 
HDL-cholesterol in the top tercile (≥ 55mg/dL) 
had a risk of hypertension halve that those in 
the bottom tercile (RR = 0.54; 95%CI: 0.33-0.90). 
Other lipid parameters had no significant effect 
on the outcome. High HDL-cholesterol showed 
an independent protective effect on subsequent 
development of hypertension in the elderly.
Dyslipidemias; Hypertension; Aged; Cohort Studies
Introduction
Arterial hypertension is the principal risk factor 
for mortality and the second leading cause of dis-
ability adjusted life years around the world 1,2. The 
risk of developing arterial hypertension increases 
markedly with age 3,4, and is the most common 
chronic disease in the elderly, with prevalence of 
about 60% in Latin America and the Caribbean 5,
as well as in the town of Bambuí, Minas Gerais 
State, Brazil 6. Populations in these countries are 
aging fast 7 and unless effective primary and sec-
ondary prevention measures are implemented, 
this demographic change will bring about a sig-
nificant increase in the burden of arterial hyper-
tension in this region of the world.
Hypertension and dyslipidemia are widely 
recognized risk factors for cardiovascular dis-
ease 2,8. And yet, the pathophysiology of the 
association between hypertension and dys-
lipidemias is still not completely understood 9. 
Several mechanisms have been postulated to ex-
plain this association. Atherosclerosis – caused in 
great part by dyslipidemias 9 – leading to struc-
tural changes that result in the decreased elas-
ticity of large arteries, is generally viewed as the 
principal pathophysiologic alteration contribut-
ing to the emergence of arterial hypertension in 
the elderly 10. By altering vasomotor mechanisms 
mediated by nitric oxide, dyslipidemias also alter 
endothelial function 11, which in turn can cause 
increases in blood pressure. Renal microvascular 
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injuries due to dyslipidemias are also postulated 
to contribute to arterial hypertension 12. Finally, 
coincident genetic factors, such as having chro-
mosomal regions related to blood pressure and 
dyslipidemias in common 13,14, which predispose 
for the concomitant occurrence of hypertension 
and dyslipidemia 15, and the fact that reductions 
in blood pressure in hypertensive individuals 
have been attributed to use of statins 16, suggest 
shared pathophysiologic mechanisms that need 
to be better elucidated.
Several studies have examined prospectively 
whether elevated lipid levels are associated with 
the subsequent development of hypertension in 
middle age adults. In most studies, high-density 
lipoprotein cholesterol (HDL-C) levels show an 
independent and inverse association with in-
cident hypertension 17,18,19,20,21. Higher levels 
of triglycerides 18,20,22, higher total cholesterol 
(total-C) 19,21, higher non-HDL cholesterol (non-
HDL-C) 19,21, and higher levels of low density 
lipoprotein cholesterol (LDL-C) 17,20 have been 
found to be associated with an increased risk 
of hypertension in some studies, but not in all. 
Nevertheless, the finding of these studies are not 
entirely comparable, as the participants of the 
various cohorts differed in terms of age, gender 
(some studies included only men and others only 
women), socioeconomic status, ethnicity and the 
way in which information about hypertension 
was obtained (self-reported or objective mea-
sure), among other relevant aspects.
Moreover, the role of dyslipidemia in pre-
dicting hypertension in the elderly has received 
little attention. To our knowledge, a single previ-
ous cohort study on the issue was carried out in 
the elderly 23. This study followed 187 initially 
non-hypertensive elderly; over an eight year 
follow-up period there were 44 incident cases. 
HDL-C had a protective effect on the incidence 
of hypertension (univariate relative risk – RR =
0.8 per 5mg/dL; 95% confidence intervals – 
95%CI: 0.42-1.0).
We used data from three years of follow-up of 
the Bambuí Health and Aging Study to examine 
whether lipid parameters predict subsequent de-
velopment of hypertension in old age.
Methods
Study design and population
The study was conducted in Bambuí, a town of 
approximately 15,000 inhabitants, located in the 
state of Minas Gerais, in Southeastern Brazil. En-
rollment and monitoring procedures of the Bam-
buí Cohort Study of Aging have been described in 
detail elsewhere 6,24. Briefly, the baseline cohort 
population consisted of all residents aged 60 and 
over on January 1st, 1997 who were identified by 
means of a complete census in the city. Baseline 
data collection was performed from February to 
May, 1997, including standardized interviews, 
blood tests and blood pressure measurements, 
among others. Blood pressure measures were re-
peated in the third wave, which was conducted 
from March to June, 2000.
All cohort participants who were free of hy-
pertension at baseline (as defined below) and 
who did not have cardiovascular diseases were el-
igible for inclusion. Cardiovascular diseases that 
prompted exclusion were: prior medical diagno-
sis of myocardial infarction, symptoms of angina 
pectoris or intermittent claudication 25, stroke 
26 and congestive heart failure. The presence of 
congestive heart failure was objectively defined 
by a plasma B-type brain natriuretic peptide 
(BNP) level > 100pg/mL (MEIA/AxSYM; Abbott, 
Abbott Park, USA), as recommended by the man-
ufacturer, and QRS interval ≥ 120ms on ECG 27 
(Hewlett Packard M1700A; Hewlett Packard, Palo 
Alto,  USA).
Definition and measurement of blood 
pressure
Three measures of blood pressure were obtained 
at least two minutes apart. The mean of the sec-
ond and third measures was used following a 
standard protocol 28. Blood pressure was mea-
sured in the project field study clinic in the early 
morning, at least 30 minutes after consumption 
of caffeine and/or use of tobacco and after five 
minutes of rest. Measurements were taken on 
the right arm with an appropriate size cuff, us-
ing a random zero Mercury sphygmomanometer 
(Tycos 5097-30; Tycos, Arden, USA) and stetho-
scope (Littmann Cardiology II; 3M, St. Paul, 
USA). Systolic and diastolic blood pressures were 
registered using as a reference the first and the 
fifth Korotkoff sounds, respectively. The techni-
cians that measured blood pressure were certi-
fied after training at a specialized center at the 
School of Medicine of the Minas Gerais Federal 
University (Faculdade de Medicina, Universi-
dade Federal de Minas Gerais). The same proce-
dures were used at baseline and during the third 
year of follow-up.
The use of medications was measured by 
mean of verifying the packaging and/or the phy-
sician’s prescription during home visits that were 
conducted with all participants. Medications 
were coded according to the Anatomical Thera-
peutical Chemical Index (ATC/DDD Index) 29 and 
were considered antihypertensives if they were 
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classified in groups ATC: C02 – antihypertensives, 
C03 – diuretics, C07 – beta-blockers, C08 – cal-
cium channel blockers, and C09 – agents that act 
on the renin-angiotensin system.
Arterial hypertension was defined in this 
study as the presence of systolic blood pressure 
equal or higher than 140mmHg or diastolic blood 
pressure equal or higher than 90mmHg or treat-
ment for hypertension 30. We considered incident 
cases those individuals that were free of hyper-
tension at baseline and were found to be hyper-
tensive at the third follow-up visit in 2000.
Lipids dosages
Blood specimens for biochemical assays were 
collected after a recommended 12 hour fast. Se-
rum levels of total-C, HDL-C and triglycerides 
were determined by enzymatic methods, using 
standard assay kits (Boehringer Mannhein; In-
gelheim am Rhein, Germany). All the measures 
were performed using an automated analyzer 
(Eclipse Vitalab, Merck, Schiphol-Rijk, Nether-
lands) at the study’s central laboratory at the 
René Rachou Research Center of the Oswaldo 
Cruz Foundation (Centro de Pesquisas René 
Rachou, Fundação Oswaldo Cruz – CPqRR/Fi-
ocruz). Details are available from other publica-
tions 6,24. For the present analysis the follow-
ing lipid parameters were considered: total-C, 
HDL-C, non-HDL-C, total-C/HDL-C ratio and 
triglycerides.
Other measures
Other baseline measures considered in this 
study included: age, sex, schooling level (num-
ber of complete years of schooling), smoking, 
physical activities during leisure time, alcohol 
consumption (weekly frequency in previous 12 
months), parental history of cardiovascular dis-
eases (history of myocardial infarction, angina 
pectoris, hypertension and/or stroke), waist cir-
cumference, and fasting blood glucose. Current 
smokers were those who had smoked at least 100 
cigarettes in the lifetime and were still smokers. 
“No physical activities during leisure time” was 
defined by the absence of any exercise lasting 
20-30 minutes in the previous 90 days. Measures 
of waist circumference were performed using a 
flexible inelastic tape measure, with this subject 
standing.
None of the participants had a history of 
drug treatment for lowering lipids, and none 
had used these drugs during the period in which 
patients were followed. Thus, drugs for lower-
ing cholesterol were not included in the present 
analysis.
Statistical analyses
The univariate data analysis was based on Pear-
son’s chi square, Student’s t and Mann-Whitney 
rank sum tests to assess statistical significance 
of differences between frequencies, means and 
medians, respectively. The multivariate analy-
ses of predictors of incident hypertension were 
based on RR and 95%CI estimated by Poisson 
regression. Separate multivariate analyses were 
performed for each lipid parameter; these were 
categorized in increased units of ten percentiles. 
The relative risks were incrementally adjusted 
for age (continuous), sex, and schooling level 
(model 1), smoking, physical activity and alco-
hol consumption (model 2), parental history of 
cardiovascular diseases, waist circumference 
(continuous), blood glucose in log values (con-
tinuous) (model 3) and systolic blood pressure 
(model 4). A complementary multivariate analy-
sis was implemented based on categorical values 
of HDL-C to assess its association with incident 
hypertension. The significance of multiplicative 
interactions between HDL-C with age or sex on 
the outcome was examined by using cross-prod-
uct terms in Poisson regression models. Statis-
tical analyses were conducted using Stata 11.0 
statistical software (Stata Corp., College Station, 
USA). All p-values were 2-tailed (α = 0.05).
The Bambuí cohort study was approved by 
the Ethics Research Committee of Fiocruz. Par-
ticipants signed an informed consent at enroll-
ment and at each follow-up visit.
Results
Of 1,742 Bambuí residents aged 60 years and 
over, 1,494 (85.8%) had had their blood pres-
sure measured at baseline. Of these, 464 were 
classified as non-hypertensive. Eighty-five with 
existing cardiovascular disease were excluded. 
Of the 379 eligible elderly, 306 had a blood pres-
sure measure recorded at the third year of fol-
low-up and constitute the population base for 
this study. The other 73 included 55 who had 
died and 18 who had emigrated or declined to 
participate.
The baseline characteristics of study partici-
pants are shown in Table 1. Mean age was 68.0 
(standard deviation – SD = 6.7) years and wom-
en (54.2%) outnumbered men. The number of 
years of formal schooling was very low: 62.4% 
had completed less than four years of school. 
The mean (SD) levels total-C, HDL-C, non-
HDL-C, total-C/HDL-C ratio were 230.3mg/
dL (49.4), 50.0mg/dL (13.8), 180.3mg/dL (49.8) 
and 4.9mg/dL (1.7), respectively. The median 
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Table 1
Baseline characteristics of study participants. The Bambuí Cohort Study of Aging.
Characteristics % or mean (SD) or median (IQR) 
(N = 306)
Total cholesterol in mg/dL [mean (SD)] 230.3 (49.4)
HDL cholesterol in mg/dL [mean (SD)] 50.0 (13.8)
Non-HDL cholesterol in mg/dL [mean (SD)] 180.3 (49.8)
Total cholesterol / HDL cholesterol ratio [mean (SD)] 4.9 (1.7)
Triglycerides in mg/dL [median (IQR)] 115.5 (84-161)
Age [mean (SD)] 68.0 (6.7)
Female sex (%) 54.2
Less than 4 years of schooling (%) 62.4
Current smoking (%) 18.6
Absence of physical activities during leisure times in previous 90 days * (%) 23.1
Alcohol consumption: 1-6 drinks a week in previous 12 months (%) 5.2
Parental history of cardiovascular diseases < 50 years (%) 23.9
Waist circumference in centimeters [mean (SD)] 88.3 (10.3)
Blood glucose in mg/dL, [geometric mean (SD)] 96.0 (88-106)
Systolic blood pressure in mmHg [mean (SD)] 120.7 (12.1)
Diastolic blood pressure in mmHg [mean (SD)] 75.8 (8.4)
IQR: interquartile range; SD: standard deviation.
* Exercises for 20-30 minutes less than 3 times a week;
Table 2
Univariate analysis of the association between baseline characteristics and incident hypertension. The Bambuí Cohort Study of Aging.
Baseline characteristics Incident hypertension p-value *
Yes (n = 114) No (n = 192)
% or mean (SD) % or mean (SD)
Total cholesterol in mg/dL [mean (SD)] 229.7 (51.8) 230.7 (48.1) 0.861
HDL cholesterol in mg/dL [mean (SD)] 46.7 (12.4) 52.0 (14.2) 0.001
Non-HDL cholesterol in mg/dL [mean (SD)] 182.9 (53.2) 178.7 (47.7) 0.474
Total cholesterol/HDL cholesterol ratio [mean (SD)] 5.3 (1.9) 4.7 (1.5) 0.006
Triglycerides in mg/dL [median (IQR)] 122.5 (86-156) 110 (82-161) 0.380
Age [mean (SD)] 67.7 (6.6) 68.3 (6.8) 0.516
Female sex (%) 54.2 57.0 0.454
Less than 4 years of schooling (%) 62.0 61.4 0.778
Current smoking (%) 21.0 17.2 0.401
Absence of physical activities during leisure times in previous 90 days (%) 86.0 74.0 0.014
Alcohol consumption: 1-6 drinks a week in previous 12 months (%) 6.1 4.7 0.581
Parental history of cardiovascular diseases < 50 years (%) 21.1 15.6 0.229
Waist circumference in centimeters [mean (SD)] 89.8 (11.0) 87.4 (9.9) 0.051
Blood glucose in mg/dL [median (IQR)] 98 (90-107) 95 (87-105) 0.167
Systolic blood pressure in mmHg [mean (SD)] 124.4 (10.9) 118.5 (12.3) < 0.001
Diastolic blood pressure in mmHg [mean (SD)] 78.2 (8.2) 74.3 (8.3) < 0.001
IQR: interquartile range; SD: standard deviation.
* p-value: Pearson’s chi square, Student’s t and Mann-Whitney rank sum tests for differences between frequencies, means and medians, respectively.
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triglyceride level was 115.5mg/dL (interquartile 
range – IQR = 84-161).
The cumulative incidence of hypertension 
over three years was 37.3%. Results of the uni-
variate analysis of factors associated with the 
development of hypertension are presented in 
Table 2. Statistically significant (p < 0.05) asso-
ciations with incident hypertension were ob-
served for total-C/HDL-C ratio, HDL-C, absence 
of physical activity during leisure time, systolic 
blood pressure, and diastolic blood pressure. 
Waist circumference was at the borderline of the 
statistical significance. Other variables did not 
reach statistical significance in this analysis.
After adjustments for potential confounding 
variables (Table 3), there was a significant as-
sociation between decreased HDL-C level and 
incident hypertension (fully adjusted RR = 0.92; 
95%CI: 0.86-0.99). A significant relative risk was 
also observed for Total-C/HDL ratio in the analy-
sis adjusted by socio-demographic variables, but 
this association disappeared after adjustments 
for lifestyle and other relevant characteristics. 
Total-C, non-HDL-C and triglycerides were not 
found to be associated with the risk of hyperten-
sion in any of the multivariate models.
A HDL-C level in the top tercile (55mg/dL 
and over) in comparison with the bottom tercile 
showed an independent and protective effect for 
incident hypertension (fully adjusted RR = 0.54; 
95%CI: 0.33-0.90) (Table 4). No significant effect 
modifiers between age and sex on the associa-
tion between HDL-C and incident hypertension 
(p-value for interaction = 0.249 for age and 0.738 
for sex) was found.
Discussion
This study provides epidemiological evidence of 
a protective effect of HDL-C level on the risk of 
hypertension in an elderly population initially 
free of cardiovascular diseases. This association 
persisted after adjustments for several potential 
confounding variables, including baseline sys-
tolic blood pressure level, and suggests a graded 
effect. Low HDL-C appears to precede the devel-
opment of hypertension by at least three years.
Population-based studies of the incidence of 
arterial hypertension in Brazil are rare. To our 
knowledge there is only one population-based 
cohort study of middle-aged individuals on this 
issue. This study was conducted in the city of 
Porto Alegre, Rio Grande do Sul State, South of 
Brazil 31. Among 589 normotensive individuals 
(mean age = 39 years), 127 (21.6%) developed 
arterial hypertension after a mean follow-up of 
5.6 years. After adjustments for relevant char-
acteristics, age and waist/height ratio were the 
only factors that remained significantly associ-
ated with the incidence of arterial hypertension. 
The present study was conducted in an older 
community-based cohort (mean age = 68 years). 
The 3-year incidence of hypertension was higher 
(37.3%) than that of the above mentioned study, 
but similar to that observed among elderly par-
ticipants of the Framingham Study cohort, over 
the course of four years of follow-up 32.
HDL-C levels are importantly affected by 
age, and a protective effect of increased HDL-C 
level on incident hypertension in the elderly is 
plausible. Longitudinal studies have shown that 
there is a decline in serum HDL-C levels with in-
creasing age 33,34, while in cross-sectional stud-
Table 3
Multivariate-adjusted relative risks (RR) and 95% confi dence intervals (95%CI) for ten percentile unit increments in each lipid 
parameter. The Bambuí Cohort Study of Aging.
Baseline lipid parameter Model 1 Model 2 Model 3 Model 4
RR (95%CI) RR (95%CI) RR (95%CI) RR (95%CI) 
Total cholesterol 0.98 (0.91-1.04) 0.98 (0.91-1.04) 0.97 (0.91-1.04) 0.97 (0.91-1.04)
HDL cholesterol 0.92 (0.86-0.98) * 0.92 (0.86-0.98) * 0.93 (0.87-0.99) * 0.92 (0.86-0.99) *
Non-HDL cholesterol 1.00 (0.86-0.98) 1.00 (0.94-1.07) 1.00 (0.93-1.07) 0.99 (0.93-1.06)
Total cholesterol/HDL cholesterol ratio 1.06 (1.00-1.13) * 1.06 (0.99-1.12) 1.04 (0.97-1.12) 1.05 (0.98-1.12)
Triglycerides 1.02 (0.95-1.09) 1.02 (0.96-1.09) 1.01 (0.94-1.08) 1.01 (0.94-1.08)
Model 1: adjusted for age, sex, and schooling; Model 2: adjusted for the variables in Model 1 and smoking, physical activity, 
and alcohol consumption; Model 3: adjusted for the variables in Model 2 and parental history of cardiovascular diseases, waist 
circumference, and blood glucose; Model 4: adjusted for the variables in Model 3 and systolic blood pressure.
* p-value < 0.05 (Wald’s test).
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Table 4
Multivariate-adjusted relative risks (RR) and 95% confi dence intervals (95%CI) for incident 
hypertension, by baseline HDL cholesterol level. The Bambuí Cohort Study of Aging.
Baseline HDL cholesterol in mg/dL RR (95%CI) * p-value **
< 43 (bottom tertile) 1.00
44-54 0.75 (0.49-1.15) 0.191
≥ 55 (top tertile) 0.54 (0.33-0.90) 0.018
* Relative risk and 95% confi dence intervals estimated by Poisson regression and adjusted 
for age, sex, schooling, current smoking, physical activities, alcohol consumption, parental 
history of cardiovascular diseases, waist circumference, blood glucose and systolic blood 
pressure;
** p-value: Wald’s test.
ies, serum HDL-C levels tend to remain stable or 
increase slightly 33, suggesting that  individuals 
whose HDL-C levels remain high are more likely 
to survive. A decline in HDL-C concentration 
and function may occur secondary to hormonal 
changes, inflammatory processes, and diabetes 
mellitus. Beyond these effects, specific aging 
processes may be involved 35. In a metanalysis 
of 61 prospective studies, mostly in Western Eu-
rope and North America, the association of age, 
gender, and blood pressure with total-C, HDL-C 
and LDL-C, was evaluated in relation to cardio-
vascular mortality. Low HDL-C was identified as 
a strong and independent predictor of mortality 
from ischemic heart disease, both in middle age 
and in the elderly 36.
Low serum HDL-C levels contributed to 
structural and functional alterations which led to 
arterial rigidity 35. Studies carried out in animal 
models 37 and humans 38 showed that low HDL-C 
levels are associated with significant endothelial 
dysfunction and compromised peripheral vaso-
dilatation. In autopsies of elderly Japanese wom-
en, it was observed that serum HDL-C levels were 
inversely associated with atherosclerosis of me-
dium and large arteries 39. Epidemiologic stud-
ies involving elderly and middle age individuals 
demonstrated an inverse relationship between 
serum HDL-C levels and arterial rigidity 40,41,42. 
The hardened arteries, in turn, lead to an increase 
in the speed of return of arterial pressure waves 
reflected from the peripheral circulation, so that 
there is an increase in peak systolic blood pres-
sure 10,43. Added to this, increased blood pressure 
itself can intensify arterial stiffening and compro-
mise endothelium-dependent vasodilatation 44. 
In one of the analyses of the Framingham Heart 
Study, Franklin et al. 45 showed that the continu-
ous increase in systolic blood pressure after 60 
years of age has a strong relationship with the 
increasing in large artery stiffness and that even 
a high normal systolic blood pressure may inten-
sify the arterial rigidity, resulting in a vicious cycle 
that culminates in arterial hypertension. It seems 
that is atherosclerosis, provoked in great part by 
the dyslipidemia 9, promotes structural and func-
tional alterations that result in reduced elasticity 
of the large arteries: principal pathophysiologic 
alteration of the emergence of arterial hyperten-
sion in the elderly 10.
Strengths of this study include the communi-
ty-based sample, the standardized and systemat-
ic measures of parameters at baseline, standard-
ized blood pressure measures at baseline and at 
follow-up, and minimal loss of participants to 
follow-up. This allowed a meaningful estimate of 
a three-year accumulative risk of hypertension. 
This study has some limitations. There were only 
114 incident cases of hypertension among cohort 
members. This potentially limits the statistical 
power to detect small effects in our analysis. Be-
cause blood pressure measurements were per-
formed in a single day, our results are subject to 
effects of regression to the mean, which would 
tend to underestimate the strength of the asso-
ciations found. Residual confounding is a pos-
sibility. Nevertheless, we were able to adjust rela-
tive risks for socio-demographic variables and 
traditional cardiovascular risk factors. Observer 
bias is unlikely because blood pressure measures 
and lab tests were performed independently, and 
without knowledge of the respective results.
Lower serum levels of HDL-C went unrec-
ognized as a predictor of subsequent hyperten-
sion for a long time. Only recently has evidence 
emerged from cohort studies indicating an in-
verse association between HDL-C and incident 
hypertension in middle-aged 17,18,19,20,21 and old-
er 23 persons in North America and/or Western 
Europe. Our study extends this observation to a 
Brazilian elderly population. The consistency of 
this association suggests that HDL-C measure-
ments may be useful to identify persons at in-
creased risk of hypertension in primary care set-
tings for prevention.
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Resumo
O objetivo do estudo foi examinar o valor prognóstico 
de parâmetros lipídicos para a incidência de hiper-
tensão arterial em idosos vivendo na comunidade. A 
pesquisa incluiu 306 (81% do total) pessoas com idade 
≥ 60 anos que estavam livres de hipertensão e de do-
enças cardiovasculares na linha de base do Estudo de 
Coorte de Idosos de Bambuí. A incidência acumulada 
em três anos da hipertensão arterial foi de 37.3%. O 
risco relativo (RR) para a incidência da hipertensão 
diminuiu 0,92 para cada unidade de colesterol HDL 
(IC95%: 0,86-0,99), independente de vários potenciais 
fatores de confusão. Indivíduos com colesterol HDL no 
tercil superior (≥ 55mg/dL) apresentaram metade do 
risco de hipertensão que aqueles no tercil inferior (RR =
0,54; IC95%: 0,33-0,90). Os outros parâmetros lipídicos 
não apresentaram efeitos estatisticamente significan-
tes sobre o evento. Valores mais altos de colesterol HDL 
apresentaram efeito protetor para o desenvolvimento 
da hipertensão em idosos.
Dislipidemias; Hipertensão; Idoso; Estudos de Coortes
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